| Anal Squamous Cell Carcinoma studied in …STUDIED_INderived51 of 51show fewer |
|---|
| → studied in | NCT02314169Phase 2 · active not recruiting Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer · condition mapped ONTOLOGY_EXACT · 51 trials mapped (30 active) | — | — | Anal Canal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07217171Phase 1 · recruiting A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas · condition mapped ONTOLOGY_EXACT · 51 trials mapped (30 active) | — | — | Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03074513Phase 2 · active not recruiting Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors · condition mapped ONTOLOGY_EXACT · 51 trials mapped (30 active) | — | — | Human Papillomavirus-Related Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04166318Phase 2 · active not recruiting Lower-Dose Chemoradiation in Treating Patients With Early-Stage Anal Cancer, the DECREASE Study · condition mapped ONTOLOGY_EXACT · 51 trials mapped (30 active) | — | — | Anal Basaloid Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04444921Phase 3 · active not recruiting EA2176: Phase 3 Clinical Trial of Carboplatin and Paclitaxel +/- Nivolumab in Metastatic Anal Cancer Patients · condition mapped CURATED_BROADER · 51 trials mapped (30 active) | — | — | Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03233711Phase 3 · active not recruiting Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer · condition mapped ONTOLOGY_EXACT · 51 trials mapped (30 active) | — | — | Anal Basaloid Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07602842Phase 1/Phase 2 · recruiting A Study of IDP-001 in Advanced or Metastatic Solid Tumors · condition mapped ALIAS · 51 trials mapped (30 active) | — | — | Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05328765completed A Global Record of Patients With Anal Squamous Cell Carcinoma With and Without HIV Infection · condition mapped ONTOLOGY_EXACT · 51 trials mapped (30 active) | — | — | Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06628570NA · recruiting Screening Strategies Among High-risk Populations for Anal Cancer · condition mapped ALIAS · 51 trials mapped (30 active) | — | — | Human Papillomavirus-Related Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06651957active not recruiting Anal High-risk HPV, HSIL, and Microbiome Among Hispanic Peoples Living With HIV (PLWH) · condition mapped ONTOLOGY_EXACT · 51 trials mapped (30 active) | — | — | Human Papillomavirus-Related Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07425054Phase 2 · recruiting ctHPVDNA Response-Adapted Chemoradiation +/- Retifanlimab Treatment in Locally-Advanced Anal Cancer · condition mapped ALIAS · 51 trials mapped (30 active) | — | — | Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03712566active not recruiting Multi-Omic Assessment of Squamous Cell Cancers Receiving Systemic Therapy · condition mapped ONTOLOGY_EXACT · 51 trials mapped (30 active) | — | — | Anal Canal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07692152Phase 3 · recruiting Sintilimab Versus Mitomycin in Combination With Capecitabine and IMRT for Limited-stage Anal Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 51 trials mapped (30 active) | — | — | Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07680088Phase 2 · not yet recruiting Phase 2 Study of Pembrolizumab and Lenvatinib in Anal Squamous Cell Cancer · condition mapped ONTOLOGY_EXACT · 51 trials mapped (30 active) | — | — | Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04929028Phase 2 · active not recruiting Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer · condition mapped ONTOLOGY_EXACT · 51 trials mapped (30 active) | — | — | Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05639972Phase 1/Phase 2 · recruiting E7 T-cell Receptor (TCR) -T Cell Induction Therapy for Locoregionally Advanced HPV-associated Cancers · condition mapped ALIAS · 51 trials mapped (30 active) | — | — | Human Papillomavirus-Related Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05686226Phase 2 · recruiting E7 TCR-T Cell Immunotherapy for Human Papillomavirus (HPV) Associated Cancers · condition mapped ALIAS · 51 trials mapped (30 active) | — | — | Human Papillomavirus-Related Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06050707Phase 2 · recruiting MR-Adaptive Radiation Therapy for Anal Cancer With EScalated-Treatment in a Risk-Optimized Approach · condition mapped ONTOLOGY_EXACT · 51 trials mapped (30 active) | — | — | Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07555678Phase 2 · recruiting Chemoradiotherapy and Anti-PD-1 Antibody in Anal Squamous Cell Cancer：Chase · condition mapped ALIAS · 51 trials mapped (30 active) | — | — | Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02437851Phase 2 · completed Surgery in Treating Patients With Early Stage Anal Canal or Perianal Cancer and HIV Infection · condition mapped ONTOLOGY_EXACT · 51 trials mapped (30 active) | — | — | Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04857528recruiting Detecting HPV DNA in Anal and Cervical Cancers · condition mapped ALIAS · 51 trials mapped (30 active) | — | — | Human Papillomavirus-Related Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03260023Phase 1/Phase 2 · active not recruiting Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers · condition mapped ALIAS · 51 trials mapped (30 active) | — | — | Human Papillomavirus-Related Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05838391NA · recruiting Adaptive Radiation in Anal Cancer · condition mapped ONTOLOGY_EXACT · 51 trials mapped (30 active) | — | — | Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07085845NA · completed The Self-Sampling Pilot Study · condition mapped ALIAS · 51 trials mapped (30 active) | — | — | Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06640283Phase 2 · recruiting Dynamic ctDNA Assessment in Cervical and Anal Canal Tumors: Optimizing Follow-up and Clinical Outcomes · condition mapped ALIAS · 51 trials mapped (30 active) | — | — | Human Papillomavirus-Related Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05973487Phase 1 · active not recruiting A Basket Study of Customized Autologous TCR-T Cell Therapies in Patients With Locally Advanced (Unresectable) or Metastatic Solid Tumors · condition mapped ALIAS · 51 trials mapped (30 active) | — | — | Human Papillomavirus-Related Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06236464recruiting Identification of the Pathogenetic Mechanisms Underlying Squamous Cell Carcinomas · condition mapped ALIAS · 51 trials mapped (30 active) | — | — | Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03061435NA · recruiting Screening for Anal Cancer in Women With High-grade Vulvar Dysplasia or Vulvar Cancer. · condition mapped ALIAS · 51 trials mapped (30 active) | — | — | Human Papillomavirus-Related Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03894618Phase 1 · completed SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas · condition mapped ALIAS · 51 trials mapped (30 active) | — | — | Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06697964recruiting High Resolution Anuscopy Study · condition mapped ONTOLOGY_EXACT · 51 trials mapped (30 active) | — | — | Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04719988Phase 2 · active not recruiting Anti-PD-1 and mDCF Followed by Chemoradiotherapy in Patients With Stage III Squamous Cell Anal Carcinoma. · condition mapped CURATED_BROADER · 51 trials mapped (30 active) | — | — | Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05060471Phase 2 · completed PD-1 Blockade Combined With Chemotherapy Followed by Concurrent Immunoradiotherapy for Locally Advanced SCCA Patients · condition mapped ONTOLOGY_EXACT · 51 trials mapped (30 active) | — | — | Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06505551Phase 1/Phase 2 · not yet recruiting Phase 1/2 Study of Autologous SCG142 TCR T Cells in Patients With HPV16/52-positive Carcinoma · condition mapped ALIAS · 51 trials mapped (30 active) | — | — | Human Papillomavirus-Related Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05130073completed 4-Point Therapy Response Score With PET/CT for Anal Squamous Cell Cancer · condition mapped ONTOLOGY_EXACT · 51 trials mapped (30 active) | — | — | Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04894370Phase 2 · recruiting Combination of Spartalizumab, mDCF and Radiotherapy in Patients With Metastatic Squamous Cell Anal Carcinoma · condition mapped ALIAS · 51 trials mapped (30 active) | — | — | Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05438836recruiting Re-optimization Based Online Adaptive Radiotherapy of Anal Cancer · condition mapped ONTOLOGY_EXACT · 51 trials mapped (30 active) | — | — | Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03690921Phase 2 · completed Linear Energy Transfer (LET)-Optimized Intensity Modulated Proton Therapy (IMPT) as a Component of Definitive Chemoradiation for Newly Diagnosed Squamous Cell Carcinoma of the Anal Canal: a Feasibility Trial · condition mapped ONTOLOGY_EXACT · 51 trials mapped (30 active) | — | — | Anal Canal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02560298Phase 2 · unknown Cisplatin and Fluorouracil Compared With Carboplatin and Paclitaxel in Treating Patients With Inoperable Locally Recurrent or Metastatic Anal Cancer · condition mapped ONTOLOGY_EXACT · 51 trials mapped (30 active) | — | — | Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05582031Phase 2 · withdrawn Regorafenib With Tislelizumab in Patients With Selected Mismatch Repair-Proficient/Microsatellite Stable Cancers · condition mapped ONTOLOGY_EXACT · 51 trials mapped (30 active) | — | — | Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03517488Phase 1 · completed A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors · condition mapped ALIAS · 51 trials mapped (30 active) | — | — | Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04596033Phase 1 · terminated TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy · condition mapped ONTOLOGY_EXACT · 51 trials mapped (30 active) | — | — | Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05374252Phase 3 · unknown Chemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma Patients · condition mapped ONTOLOGY_EXACT · 51 trials mapped (30 active) | — | — | Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03221400Phase 1/Phase 2 · unknown PEN-866 in Patients With Advanced Solid Malignancies · condition mapped ALIAS · 51 trials mapped (30 active) | — | — | Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04499352Phase 2 · withdrawn A Study to Test BI 754091 Alone or in Combination With BI 836880 in People Who Have Advanced Anal Cancer · condition mapped ONTOLOGY_EXACT · 51 trials mapped (30 active) | — | — | Anal Canal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03944252Phase 2 · unknown Cetuximab + Avelumab or Avelumab Alone for Unresectable, Locally Advanced or Metastatic Squamous Cell Anal Carcinoma (SCCAC) Progressed After at Least One Line of Systemic Treatment (CARACAS) · condition mapped ALIAS · 51 trials mapped (30 active) | — | — | Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01285778Phase 2 · completed Vectibix for the Treatment of Anal Cancer · condition mapped ONTOLOGY_EXACT · 51 trials mapped (30 active) | — | — | Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02407561terminated Prospective Validation Study for the Proprietary Rectal and Anal Cancer Protein Expression Assays · condition mapped ONTOLOGY_EXACT · 51 trials mapped (30 active) | — | — | Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01807546Phase 2 · completed Oral Rigosertib for Squamous Cell Carcinoma · condition mapped ONTOLOGY_EXACT · 51 trials mapped (30 active) | — | — | Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01115790Phase 1 · completed A Phase 1 Study in Participants With Advanced Cancer · condition mapped ONTOLOGY_EXACT · 51 trials mapped (30 active) | — | — | Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02051868Phase 2 · unknown International Multicentre Study in Advanced Anal Cancer Comparing Cisplatin Plus 5 FU vs Carboplatin Plus Weekly Paclitaxel · condition mapped ALIAS · 51 trials mapped (30 active) | — | — | Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02162641withdrawn Study to Determine the Feasibility of Sentinel Node Biopsy in Patients With Anal Cancer · condition mapped ALIAS · 51 trials mapped (30 active) | — | — | Anal Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |